Sophia Patel

Dr. Sophia Patel

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2021 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
NBNatalie Bhesania
Natalie Bhesania
PSPraveen Kumar Conjeevaram Selvakumar
Praveen Kumar Conjeevaram Selvakumar
SPSophia Patel
Sophia Patel
Eosinophilic esophagitis (EoE) is a disease entity that has become increasingly recognized in the pediatric population over the last decade and was first recognized as early as 1990. EoE is a clinicopathologic diagnosis with signs and symptoms varying between age groups. The clinical presentation of EoE is variable ranging from milder nonspecific symptoms, such as abdominal pain, vomiting, and dyspepsia, to more severe presentations such as failure to thrive, dysphagia and even food impaction and is dependent on age of diagnosis 2. There is growing body of evidence with regards to the pathophysiology, diagnostic modalities, and treatment options for EoE in the past decade. In this review article, we aim to discuss the disease burden, pathophysiology, diagnostic strategies, and currently available treatment options for EoE based on existing literature.

18 June 2024 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
SPSophia Patel
Sophia Patel

6 March 2023 in Livers
Verified
Journal Article
Open access
PDF file
AAAmala James Alenchery
Amala James Alenchery
SPSophia Patel
Sophia Patel
LMLori Mahajan
Lori Mahajan
JKJacob A Kurowski
Jacob A Kurowski
SWSarah Worley
Sarah Worley
Mohammad Nasser KabbanyMohammad Nasser Kabbany
Mohammad Nasser Kabbany
There is no single proven therapy that prolongs hepatic transplant-free survival in patients with primary sclerosing cholangitis (PSC). Oral vancomycin (OV) has shown some benefit in small pediatric and adult series. We describe the effect of OV on pediatric onset PSC at our tertiary hospital. This is a single-center, retrospective, descriptive case series involving patients (<21 years at diagnosis) with PSC on OV from 2001 till 2021. The therapy effect was assessed based on symptoms, biochemical labs, imaging and liver biopsy at six and twelve months, and then annually until therapy was discontinued. The inclusion criteria identified 17 patients. Baseline GGT (n = 17) was elevated among 88.2% which then normalized among 53.8% (n = 13) at six months and 55.6% (n = 9) at one year post-OV. Baseline ALT normalized in 58.8% (n = 17) at six months and 42.8% (n = 14) at one year. Imaging findings within one year of OV revealed improved/stable biliary findings among 66.7% (n = 8/12). No adverse events were reported. OV was associated with an improvement in bile duct injury marker (GGT) after at least six months of therapy, with no disease progression on imaging within one year of therapy.

27 January 2022 in Cureus
Verified
Journal Article
Open access
CCCharles B. Chen
Charles B. Chen
JBJessica Clinic Children's Barry
Jessica Clinic Children's Barry
PSPraveen K. Conjeevaram Selvakumar
Praveen K. Conjeevaram Selvakumar
SHSandra Hong
Sandra Hong
LMLori Mahajan
Lori Mahajan
SPSophia Patel
Sophia Patel
Eosinophilic esophagitis is a chronic, immune-mediated esophageal condition that may lead to impairment of quality of life in pediatric and young adult patients. We performed a prospective, cross-sectional study on 40 patients between the ages of 2-21 years with an established diagnosis of eosinophilic esophagitis. The study evaluated physical, emotional, social, and school functioning in patients undergoing treatment with proton pump inhibitors, dietary elimination, or swallowed corticosteroids. There were no statistically significant differences in total or domain-specific quality of life scores between proton pump inhibitors, dietary elimination, and swallowed corticosteroid therapy. Overall, total and domain-specific quality of life were well-preserved in patients with eosinophilic esophagitis, with the highest scores reported in social functioning. There were also no statistically significant associations between clinical, endoscopic, and histologic features and quality-of-life measures.

24 November 2025
Verified
Book Chapter
Closed access
PDF file
SPSophia Patel
Sophia Patel
BSBrian Schroer
Brian Schroer
MHMaria Haught
Maria Haught
DSDiana Schnee
Diana Schnee